Search

Search Constraints

You searched for: Author/Creator Savitz, Adam

Search Results

11. Paliperidone palmitate: Japanese postmarketing mortality results in patients with schizophrenia. (2nd October 2016)

13. Pharmacokinetics, safety, and tolerability of paliperidone palmitate 3‐month formulation in patients with schizophrenia: A phase‐1, single‐dose, randomized, open‐label study. (5th October 2015)

14. Practical guidance for dosing and switching from paliperidone palmitate 1 monthly to 3 monthly formulation in schizophrenia. (2nd November 2015)

15. Prospective dose selection and acceleration of paliperidone palmitate 3‐month formulation development using a pharmacometric bridging strategy. (24th July 2016)